Proposed Collection; 60-Day Comment Request; Collection of Customer Service, Demographic, and Smoking/Tobacco Use Information From the National Cancer Institute's (NCI) Cancer Information Service (CIS), 81088-81089 [2024-23127]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
81088
Federal Register / Vol. 89, No. 194 / Monday, October 7, 2024 / Notices
organizations; private-sector entities;
researchers and academic institutions;
people living with and who experience
risk for disease; and other interested
constituents on Strategic Plans to serve
as national roadmaps to guide efforts to
address HIV, sexually transmitted
infections (STI), and viral hepatitis, and
to improve and enhance the
development and use of vaccines in the
United States.
DATES: To be assured consideration,
comments must be received at the
addresses provided below, no later than
5:00 p.m. ET on December 6, 2024.
ADDRESSES: Submissions must be
submitted electronically via the
following website: https://
app.smartsheetgov.com/b/form/
68aa1bd9c54b42829f99e85cc4ab1e82.
FOR FURTHER INFORMATION CONTACT:
Questions about this RFI should be
directed to Nathan Fecik; Phone: 202–
795–7616; Email: Syndemics@hhs.gov.
SUPPLEMENTARY INFORMATION: OIDP
requests feedback on the development
of the following (collectively referred to
as the Strategic Plans):
• National HIV/AIDS Strategy for the
United States: 2026–2030 (NHAS)
• Sexually Transmitted Infections
National Strategic Plan for the United
States: 2026–2030 (STI Plan)
• Vaccines National Strategic Plan for
the United States: 2026–2030
(Vaccines Plan)
• Viral Hepatitis National Strategic Plan
for the United States 2026–2030 (Viral
Hepatitis Plan)
The National HIV/AIDS Strategy for
the United States: 2022–2025 (https://
files.hiv.gov/s3fs-public/NHAS-20222025.pdf), the Sexually Transmitted
Infections National Strategic Plan for the
United States: 2021–2025 (https://
www.hhs.gov/sites/default/files/STINational-Strategic-Plan-2021-2025.pdf),
the Vaccines National Strategic Plan:
2021–2025 (https://www.hhs.gov/sites/
default/files/HHS-Vaccines-Report.pdf),
and the Viral Hepatitis National
Strategic Plan for the United States: A
Roadmap to Elimination: 2021–2025
(https://www.hhs.gov/sites/default/files/
Viral-Hepatitis-National-Strategic-Plan2021-2025.pdf) expire at the end of
calendar year 2025.
OIDP, in collaboration with the White
House Office of National AIDS Policy
(focused specifically on the NHAS) and
Federal partners, is leading work to
develop the next iteration of these
interrelated Strategic Plans through
2030. As the next NHAS will be
developed in parallel with the three
national strategic plans, OIDP is
collecting information for the 2026–
VerDate Sep<11>2014
17:11 Oct 04, 2024
Jkt 262001
2030 National HIV/AIDS Strategy at the
request of the White House Office of
National AIDS Policy. OIDP invites
community input as people have served
as the cornerstone for developing the
Strategic Plans since their inception.
Background: The Strategic Plans serve
as national roadmaps for a broad range
of constituents to help prevent,
diagnose, treat, and cure disease,
improve health outcomes, reduce health
disparities and inequities, and advance
research and technology. The plans
include a common vision, overarching
goals, objectives, and strategies, and
indicators to measure national progress
toward established targets.
The development of the next iteration
of the Strategic Plans will serve as an
opportunity to incorporate the latest
epidemiological data; review progress
toward achieving national strategic plan
goals; center the needs of populations
disproportionately affected; address
gaps identified in existing Strategic
Plans; integrate the latest scientific
advances; prioritize the most effective
strategies for achieving national goals;
and further emphasize the need to
implement integrated syndemic
approaches (https://www.hiv.gov/blog/
defining-the-term-syndemic) that cut
across each of the Strategic Plans and
address common root causes of
infectious diseases.
OIDP, in collaboration with Federal
partners, is updating the Strategic Plans
at the same time because these
conditions often disproportionately
affect similar populations and may
share common root causes. The Vaccine
National Strategic Plan is included in
this coordinated process to elevate the
critical role vaccines can serve as a key
intervention to prevent infectious
disease, including STIs and viral
hepatitis, and to disrupt syndemics. By
updating the Strategic Plans at the same
time, OIDP aims to identify, leverage,
and maximize Federal and other
resources to achieve health equity and
reduce related health disparities.
OIDP coordinates the development,
implementation, and monitoring of the
Strategic Plans in collaboration with
Federal partners.
Information Requested: Anyone can
submit written responses to the
questions of interest listed at the
following website: https://
app.smartsheetgov.com/b/form/
68aa1bd9c54b42829f99e85cc4ab1e82.
This feedback will inform the 2026–
2030 Strategic Plans. Please note that
responses have specified word limits.
Please provide evidence-based
justification where applicable.
Professional societies, advocacy
organizations, and other groups are
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
encouraged to submit a single collective
response that reflects the views of their
membership.
Responses to this RFI Notice are
voluntary and may be made public by
HHS. The submitted information will be
reviewed by HHS staff and may be made
available to the public, along with the
submitting individual’s name, email
address, and demographic information
consisting of the submitter’s location,
affiliated organization, role, and (if
provided) title and nature of comments.
Submitted information will not be
considered confidential, so do not
include proprietary, classified,
confidential, personal, or other sensitive
information in your response. This
request is for information and planning
purposes and should not be construed
as a solicitation or as an obligation of
the Federal Government or the HHS. No
awards will be made based on responses
to this RFI. The information submitted
will be analyzed and may be used in
reports or presentations. Those who
respond are advised that the HHS is
under no obligation to acknowledge
receipt of your comments or provide
feedback on your submission. The HHS
and the government reserve the right to
use any non-proprietary technical
information in any future solicitation(s).
Authority: 42 U.S.C. 202 and 42
U.S.C. 207.
B. Kaye Hayes,
Deputy Assistant Secretary for Infectious
Disease; Director, Office of Infectious Disease
and HIV/AIDS Policy.
[FR Doc. 2024–22948 Filed 10–4–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Collection of Customer
Service, Demographic, and Smoking/
Tobacco Use Information From the
National Cancer Institute’s (NCI)
Cancer Information Service (CIS)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide an
opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
SUMMARY:
E:\FR\FM\07OCN1.SGM
07OCN1
81089
Federal Register / Vol. 89, No. 194 / Monday, October 7, 2024 / Notices
Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact Candace Maynard, Branch
Chief, Cancer Information Service
Branch, CISB/OCPL, 9609 Medical
Center Drive, Rockville, MD 20850, or
call non-toll-free number 240–276–6657
or email your request, including your
address to: deatonc@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires written
comments and/or suggestions from the
public, and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
DATES:
Institute (NCI) currently collects (1)
customer service and demographic
information from clients of the Cancer
Information Service (CIS) to properly
plan, implement, and evaluate cancer
education efforts, including assessing
the extent by which the CIS reaches and
impacts underserved populations; (2)
smoking/tobacco use behavior of
individuals seeking NCI’s smoking
cessation assistance through the CIS to
provide smoking cessation services
tailored to the individual client’s needs
and track their smoking behavior at
follow up. This is a request for OMB to
approve a revised submission for an
additional three years to provide
ongoing customer service collection of
demographic information and collection
of brief customer satisfaction questions
from NCI Cancer Information Service
Clients for the purpose of program
planning and evaluation.
OMB approval is requested for 3
years. Respondents’ only cost is their
time. The total estimated annualized
burden hours are 6,343.
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Collection
of Customer Service, Demographic, and
Smoking/Tobacco use Information from
the National Cancer Institute’s (NCI)
Cancer Information Service (CIS), 0925–
0208, Expiration Date 03/31/2025,
REVISION, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The National Cancer
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average time
per response
(in hours)
Total annual
burden hours
Category of respondent
Demographic & Customer Satisfaction Questions
(Appendix 1A or 1AB).
Demographic & Customer Satisfaction Questions
(Appendix 1B).
Smoking Cessation ‘‘Intake’’ Questions (Appendix 1C).
Smoking Call Backs (Appendix 1D) .....................
VA Call Backs (Appendix 1E) ...............................
Cancer Info Call Backs (Appendix 1F) .................
Email Intake Form (Appendix 2) ...........................
Individuals .....................
15,754
1
3/60
788
Individuals .....................
17,589
1
2/60
586
Individuals .....................
8,839
1
6/60
884
.....................
.....................
.....................
.....................
8,840
26,055
1,841
9,740
1
1
1
1
4/60
4/60
4/60
10/60
589
1,737
123
1,623
Demographic & Customer Satisfaction Questions
(Appendix 9).
Individuals .....................
400
1
2/60
13
Totals .............................................................
.......................................
........................
113,191
........................
6,343
Individuals
Individuals
Individuals
Individuals
Dated: October 2, 2024.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–23127 Filed 10–4–24; 8:45 am]
Prospective Grant of an Exclusive
Patent License: Anti-KK–LC–1 T Cell
Receptors
BILLING CODE 4140–01–P
National Institutes of Health
AGENCY:
National Institutes of Health,
HHS.
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Form name
ACTION:
Notice.
The National Cancer Institute,
an institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
practice the inventions embodied in the
SUMMARY:
VerDate Sep<11>2014
17:11 Oct 04, 2024
Jkt 262001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Patents and Patent Applications listed
in the Supplementary Information
section of this notice to T-Cure
Biosciences, Inc. (‘‘T-Cure’’) located in
Calabasas, California.
Only written comments and/or
applications for a license which are
received by the National Cancer
Institute’s Technology Transfer Center
on or before October 22, 2024 will be
considered.
DATES:
Requests for copies of the
patent application, inquiries, and
comments relating to the contemplated
an Exclusive Patent License should be
directed to: Suna Gulay French, Ph.D.,
Technology Transfer Manager, NCI
ADDRESSES:
E:\FR\FM\07OCN1.SGM
07OCN1
]]>Agencies
[Federal Register Volume 89, Number 194 (Monday, October 7, 2024)]
[Notices]
[Pages 81088-81089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23127]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Collection of
Customer Service, Demographic, and Smoking/Tobacco Use Information From
the National Cancer Institute's (NCI) Cancer Information Service (CIS)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide an opportunity for public comment on proposed
data collection projects, the National Cancer Institute (NCI) will
publish periodic summaries of proposed projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
[[Page 81089]]
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact Candace
Maynard, Branch Chief, Cancer Information Service Branch, CISB/OCPL,
9609 Medical Center Drive, Rockville, MD 20850, or call non-toll-free
number 240-276-6657 or email your request, including your address to:
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires written comments and/or suggestions from
the public, and affected agencies are invited to address one or more of
the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: Collection of Customer Service,
Demographic, and Smoking/Tobacco use Information from the National
Cancer Institute's (NCI) Cancer Information Service (CIS), 0925-0208,
Expiration Date 03/31/2025, REVISION, National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information Collection: The National Cancer
Institute (NCI) currently collects (1) customer service and demographic
information from clients of the Cancer Information Service (CIS) to
properly plan, implement, and evaluate cancer education efforts,
including assessing the extent by which the CIS reaches and impacts
underserved populations; (2) smoking/tobacco use behavior of
individuals seeking NCI's smoking cessation assistance through the CIS
to provide smoking cessation services tailored to the individual
client's needs and track their smoking behavior at follow up. This is a
request for OMB to approve a revised submission for an additional three
years to provide ongoing customer service collection of demographic
information and collection of brief customer satisfaction questions
from NCI Cancer Information Service Clients for the purpose of program
planning and evaluation.
OMB approval is requested for 3 years. Respondents' only cost is
their time. The total estimated annualized burden hours are 6,343.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Category of Number of responses per per response Total annual
respondent respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Demographic & Customer Individuals..... 15,754 1 3/60 788
Satisfaction Questions
(Appendix 1A or 1AB).
Demographic & Customer Individuals..... 17,589 1 2/60 586
Satisfaction Questions
(Appendix 1B).
Smoking Cessation ``Intake'' Individuals..... 8,839 1 6/60 884
Questions (Appendix 1C).
Smoking Call Backs (Appendix Individuals..... 8,840 1 4/60 589
1D).
VA Call Backs (Appendix 1E)... Individuals..... 26,055 1 4/60 1,737
Cancer Info Call Backs Individuals..... 1,841 1 4/60 123
(Appendix 1F).
Email Intake Form (Appendix 2) Individuals..... 9,740 1 10/60 1,623
---------------------------------------------------------------
Demographic & Customer Individuals..... 400 1 2/60 13
Satisfaction Questions
(Appendix 9).
---------------------------------------------------------------
Totals.................... ................ .............. 113,191 .............. 6,343
----------------------------------------------------------------------------------------------------------------
Dated: October 2, 2024.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer Institute, National
Institutes of Health.
[FR Doc. 2024-23127 Filed 10-4-24; 8:45 am]
BILLING CODE 4140-01-P
